Skip to main content
ELVN filings

Corporate insider profile

Helen Louise Collins Filing Activity

Latest reported as CHIEF MEDICAL OFFICER of Enliven Therapeutics, Inc. (ELVN).

Purchase filings
0
Reported companies
1
Net open-market value
-$656,341.00
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$43.80$219,017
May 18, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$39.79$198,972
Apr 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$47.67$238,353